Assembly Biosciences Inc (NAS:ASMB) Stock News, Headlines & Updates
Assembly Biosciences Inc Stock News from GuruFocus
- 1
Jul 15, 2024
Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
Marketwired • 7:00am
Jun 18, 2024
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
Marketwired • 7:00am
Jun 17, 2024
Assembly Biosciences Announces $12.6 Million in Equity Financings
Marketwired • 7:00am
Jun 10, 2024
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
Marketwired • 7:00am
Jun 05, 2024
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
Marketwired • 7:00am
May 22, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news